Meet DermaSensor: a non-invasive, AI-powered device that provides an immediate, objective result for skin cancer risk.
50% Off for the First 3 Months – Now $199/Month (Regularly $399 for Unlimited Users & Patients)
96% sensitivity for detecting all three common skin cancers ¹
Proprietary, FDA-cleared algorithm provides instant results
First FDA device cleared for primary care use
Skin cancer is a pervasive and underdiagnosed health concern in the United States, exacerbated by the inefficiencies within the healthcare system. Primary care physicians, who are on the frontline to appropriately treat and triage a host of conditions, have had a lack of adequate diagnostic aids to assess skin lesions. There is an unmet need for tools to improve identification of lesions requiring referral, which may otherwise lead to delayed or missed detection of skin cancer.
96% sensitivity for detection across all three common skin cancers¹
Proprietary algorithm yields instant assessment.
Ergonomically designed, wireless, and easy to grip.
Always on, ensuring readiness when needed.
Identify lesions suggestive of skin cancer on the patient
Apply handheld DermaSensor device to the lesion and initiate first recording
Five spectral recordings are taken from the skin lesion to complete one scan
DermaSensor's algorithm analyzes spectral data and delivers assessment in seconds
Hassle-free returns after 90 days.
Month-to-Month & no restocking fees.
Immediate, objective result
for skin cancer risk
Save all of your data
on Cloud storage
Detection rate across all
common skin cancers ¹
Reflects and records light from the lesion’s cellular and sub-cellular structures.
The built-in computer evaluates light patterns to help physicians assess skin lesions—including melanomas, squamous cell carcinoma, and basal cell carcinoma—for referral decisions.
Based on light scattering, DermaSensor recommends either “Monitor” or “Investigate Further”. The latter includes a 1–10 confidence score for malignancy likelihood.
Elastic Scattering Spectroscopy (ESS) is supported by 30+ clinical studies, showing results comparable to histopathology in analyzing cellular structure.
Advance Your Practice — AI-Powered Skin Cancer Detection in the Palm of your Hand!
